Showing results (1611-1620 of 1,753) with videos related to
Sort By:
Pageof 176
Breast Cancer Research : BCR|April 8, 2015
Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancerSergio Granados-Principal, Yi Liu, Maria L Guevara, et al.Critical Care Medicine|September 16, 2016
Cytokine Release Syndrome After Chimeric Antigen Receptor T Cell Therapy for Acute Lymphoblastic LeukemiaJulie C Fitzgerald, Scott L Weiss, Shannon L Maude, et al.Genome Announcements|April 22, 2017
Draft Nuclear Genome Sequence of the Liquid Hydrocarbon-Accumulating Green Microalga <i>Botryococcus braunii</i> Race B (Showa)Daniel R Browne, Jerry Jenkins, Jeremy Schmutz, et al.Cancer|July 21, 2021
Evolving biological associations of upfront cytoreductive nephrectomy in metastatic renal cell carcinomaAndrew W Silagy, Ritesh R Kotecha, Stanley Weng, et al.Shock (Augusta, Ga.)|December 30, 2021
Influence of Immune Cell Subtypes on Mitochondrial Measurements in Peripheral Blood Mononuclear Cells From Children with SepsisScott L Weiss, Sarah E Henrickson, Robert B Lindell, et al.Cell Reports|December 21, 2022
BCL-xL inhibition potentiates cancer therapies by redirecting the outcome of p53 activation from senescence to apoptosisVijaya Bharti, Reese Watkins, Amrendra Kumar, et al.Journal of the Pediatric Infectious Diseases Society|November 27, 2018
Implementation of a Pragmatic Biomarker-Driven Algorithm to Guide Antibiotic Use in the Pediatric Intensive Care Unit: the Optimizing Antibiotic Strategies in Sepsis (OASIS) II StudyKevin J Downes, Julie C Fitzgerald, Emily Schriver, et al.Cyberpsychology & Behavior : the Impact of the Internet, Multimedia and Virtual Reality on Behavior and Society|January 31, 2009
Virtual environments in the diagnosis, prevention, and intervention of age-related diseases: a review of VR scenarios proposed in the EC VETERAN ProjectG Riva, A Rizzo, D Alpini, et al.ESMO Open|August 22, 2024
Impact of primary tumor sidedness and sex on prognosis and anti-epidermal growth factor receptor antibody efficacy in BRAF-mutant metastatic colorectal cancer: a pooled analysis of AIO studies FIRE-1, CIOX, FIRE-3, XELAVIRI, and VOLFIA H S Alig, D P Modest, S Stintzing, et al.Cancer Research|February 9, 2026
FASN Inhibition Enhances the Efficacy of Chemotherapy in Colorectal Cancer by Inhibiting the DNA Damage ResponseMoumita Banerjee, Yekaterina Y Zaytseva, Ellen M Reusch, et al.Pageof 176